Carol Schafer

Insider Reports History

Location
New York, NY
Signature
/s/ Carol Schafer, by Michael A. Smith as Attorney-in-fact
Transaction view
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Carol Schafer:

Form 4 holding Director

INSMED Inc

Security class
Common Stock
Shares / value
66,622
Estimated value
$10,894,029
Report date
13 May 2026
Price
$163.52
Ownership
Direct
Form 4 holding Director

Kura Oncology, Inc.

Security class
Option to purchase common stock
Shares / value
28,500
Estimated value
Report date
05 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

IDERA PHARMACEUTICALS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
26,000
Estimated value
Report date
23 Jun 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Kura Oncology, Inc.

Security class
Option to purchase common stock
Shares / value
26,000
Estimated value
Report date
05 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Immunome Inc.

Security class
Director Stock Option (right to buy)
Shares / value
18,864
Estimated value
Report date
10 Jun 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Immunome Inc.

Security class
Stock option (right to buy)
Shares / value
11,333
Estimated value
Report date
13 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Carol Schafer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .